S02 E13: Social sustainability, patient advocacy and policy campaigning

In this episode, Helena is joined by Klaus Legau, Senior Advisor, Social Sustainability at Leo Pharma. Klaus reveals the most important facets of a social sustainability strategy and where he believes the pharmaceutical industry is falling short in this respect, as well as offering expert advice to those starting out in policy campaigning.   If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:   The driving seat of organisational change https://www.emg-gold.com/post/the-driving-seat-of-organisational-change   Novartis enhances social mobility commitments https://www.emg-gold.com/post/novartis-enhances-social-mobility-commitments   A joint mission for social justice https://www.emg-gold.com/post/a-joint-mission-for-social-justice   Setting the stage for a more equitable future https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future

There are no comments yet.

Please log in to write the first comment.